Recent Updates
Recently added Catalysts
FDMT Neutral Sentiment

Aerow hits the mark for 4D Molecular

Key Takeaway: The article provides an overview of resources and updates from Evaluate, focusing on their latest blogs, reports, and webinars in the biopharma market. It highlights the importance of staying informed about industry trends and insights. The content aims to engage readers by offering timely information and expert analysis.
Price reaction · baseline $15.51 (2023-09-18 close) · hit pre-market · 2 other FDMT headline(s) in the window, move may be shared
day 0 close · peak
-3.4%

Market Sentiment Analysis

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+128%
120-day peak, hindsight
Typical move
11.2%
average across 9 past catalysts
Cash runway
~18 mo
Low dilution risk
Lead asset
4D-150 IVT
Phase 3 · Macular Neovascularization Secondary to Age-Related Macular Degeneration

Full Press Release Details

Resource Center

Looking for the latest from the Evaluate team? Below you’ll find our latest blogs, reports, webinars and more. Whether you’re looking for detailed analysis of the state of the biopharma market, or a quick primer on a particular topic, you’re in the right place.

Get all the latest content direct to your inbox.
Be the first to receive new reports, expert analysis, and key biopharma market updates from Evaluate.

Most Recent

Report/eBook
July 1, 2026
2026 Post-ASCO Sample Report
Report/eBook
June 23, 2026
World Preview 2026: Big Drugs. Bigger Questions.
Report/eBook
June 22, 2026
ASCO 2026: 6 Key Commercial Trends in Oncology
Infographic
June 10, 2026
World Preview 2026: A $2tn Industry at a Glance
Blog
June 3, 2026
How to value a biotech
Report/eBook
June 2, 2026
2026 ASCO Weekend Update
Report/eBook
May 26, 2026
2026 Pre-ASCO Report
Video Blog
May 26, 2026
ADCs remain in dealmakers’ sights. Here’s why
Blog
May 26, 2026
Meet the Team: Paul Verdin
Report/eBook
May 22, 2026
Inside the ADC Deal Surge
Report/eBook
May 20, 2026
Q2 2026 Outlook: The Catalysts That Will Define the Quarter
Webinar
REGISTRATION OPEN
Tuesday 14th July 3pm BST | 10am ET
China Pipelines, Western Portfolios

Webinars

Looking to learn? Our webinar series brings together Evaluate’s experts with industry leaders to talk about the big issues of the day.

News & Events

Check out the latest news from Evaluate and find out where you can come to meet the team.

Thought Leadership

Catch up with our insights on the big issues in pharma.

Need pharma insights?

Register for Evaluate Discovery, our monthly newsletter.

Frequently Asked Questions

What resources does Evaluate provide?

Evaluate offers blogs, reports, and webinars focused on the biopharma market.

How can I stay updated with Evaluate's content?

You can register for Evaluate Discovery, their monthly newsletter, for updates.

What topics are covered in Evaluate's reports?

Their reports cover various biopharma topics, including market trends and analyses.

When is the next Evaluate webinar scheduled?

The next webinar is on July 14th at 3pm BST / 10am ET.

Last updated: Sep 19, 2023